Delivery Order SPE2DB24D2100-SPE2DB25FBFQW
Award Date 8/5/25
Potential Completion Date 8/26/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for Ibrance 75 mg capsules (21-count unit) on July 22, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used in cancer treatment, reflecting the...
- The Defense Logistics Agency awarded a $8,123.96 delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg tablets (7-count packaging) under a firm fixed price contract, with an ultimate completion date of August 8, 2025. This competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication commonly used in cancer treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity 7) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used...
- The Defense Logistics Agency awarded a $8,118.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (21-count) on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded procurement from the company's existing pharmaceutical supply agreement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ibrance 100 mg tablets in quantities of seven under a firm fixed-price contract valued at $8,122.48. This delivery order, which is expected to be completed by August 13, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ibrance 125 mg capsules (21-count packages) under a firm fixed-price contract valued at $8,118.08, with completion scheduled for August 22, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor within the DLA's medical supply chain. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count package) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency Troop Support Medical awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 21 capsules of IBRANCE 75 MG CAPSULE. IBRANCE is a pharmaceutical product used to treat breast cancer. The place of performance for this delivery order is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from July 10, 2023 through July 31, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 21 capsules of IBRANCE 75 MG to support Conshohocken, Pennsylvania operations. IBRANCE is a pharmaceutical used to treat breast cancer. The order was placed under an unspecified multiple award contract vehicle and has a period of performance from September 8, 2023 through September 29, 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179103 IBRANCE 75 MG CAPSULE 21S. The order is being fulfilled under the prime contractor's Corporate Office Division from its place of performance in Conshohocken, Pennsylvania, with work scheduled to conclude by October 5, 2023. IBRANCE is a pharmaceutical used to treat breast cancer, and this order will support the Defense Logistics Agency's mission to provide medical...